 Amsacrine safe effective therapy patients myocardial dysfunction acute leukemia role amsacrine remission patients cardiac disease acute leukemia patients acute myelogenous leukemia AML acute lymphocytic leukemia ALL biphenotypic leukemia series patients disease left ventricular ejection fraction complete remission AML addition acute leukemia reduced ventricular ejection fraction patients endomyocardial biopsy none changes sufficient degree drug-induced heart failure Patients arrhythmias amsacrine incident serum potassium level mEq/l time drug administration Amsacrine safe effective therapy patients acute leukemia cardiac disease